Brief: Standard Biotools Reports First Quarter 2023 Financial Results
Standard BioTools Inc LAB.O :
* STANDARD BIOTOOLS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* STANDARD BIOTOOLS INC Q1 REVENUE $25.1 MILLION
* STANDARD BIOTOOLS - FOR 2023, CO SEES FLAT-TO-MODERATE
GROWTH IN
CORE PRODUCT & SERVICE REVENUE RELATIVE TO 2022 CORE PRODUCT &
SERVICE REVENUE OF $94.5 MILLION
* STANDARD BIOTOOLS INC - QTRLY LOSS PER SHARE $0.21
Source text for Eikon: ID:nGNXVHqvs
Further company coverage: LAB.O
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07